Magnus Dahlbom

University of California, Los Angeles — United States

Medicine · Health Sciences

52h-index9.6kcitations262works2.22yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(199), Radiomics and Machine Learning in Medical Imaging(58), Radiopharmaceutical Chemistry and Applications(56), Advanced MRI Techniques and Applications(49), Advanced X-ray and CT Imaging(44)

Publications262 total

177 Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study

3 cited

Journal of Clinical Oncology·2025· 3 citedOpen Access

Application of a Hand-Held Czt-Based Gamma Camera for Pre-Clinical Intratherapeutic Imaging of 177 Lu, 225 Ac, and 212 Pb

2025

Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of 177Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol

1 cited

Journal of Nuclear Medicine·2025· 1 citedOpen Access

A randomized phase 2 trial of flexible and extended dosing of 177 Lu-PSMA-617 molecular radioligand therapy in mCRPC (FLEX-MRT): Trial in progress update.

Journal of Clinical Oncology·2025

Study protocol: Phase 2 trial of re-treatment with 177Lu-PSMA-617 molecular radiotherapy for metastatic castration resistant prostate cancer (RE-LuPSMA trial).

Journal of Clinical Oncology·2025

Studienprotokoll der laufenden FLEX-MRT Studie: Randomisierte Phase-2-Studie zur FLEXiblen und erweiterten Dosierung der [177Lu]Lu-PSMA-617 Molekularen RadioTherapie (FLEX-MRT) in Patienten mit mCRPC

Nuklearmedizin - NuclearMedicine·2025

A free method for patient-specific 3D-VR anatomical modeling for presurgical planning using DICOM images and open-source software

2 cited

Methods·2025· 2 cited

Swelling of the Right Arm During a Nuclear Medicine Therapy for Metastatic Pheochromocytoma

1 cited

AACE Clinical Case Reports·2024· 1 citedOpen Access

Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease

14 cited

Journal of Nuclear Medicine·2024· 14 citedOpen Access

A randomized phase 2 trial in progress of flexible and extended dosing of 177Lu-PSMA-617 molecular radioligand therapy in mCRPC (FLEX-MRT).

1 cited

Journal of Clinical Oncology·2024· 1 cited

Tandem Isotope Therapy with225Ac- and177Lu-PSMA-617 in a Murine Model of Prostate Cancer

22 cited

Journal of Nuclear Medicine·2023· 22 citedOpen Access

Validation of a Fast-Helical Free-Breathing CT-Based Ventilation Technique Using Ventilation/Perfusion SPECT Imaging

International Journal of Radiation Oncology*Biology*Physics·2023Open Access

Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy

6 cited

Journal of Nuclear Medicine·2023· 6 citedOpen Access

Data from Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

2023Open Access

Supplementary Figures 1 - 5, Tables 1 - 3 from Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

2023Open Access

Supplementary Movie 1 from Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

2023Open Access

Supplementary Figures 1 - 5, Tables 1 - 3 from Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

2023Open Access

Supplementary Movie 2 from Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

2023Open Access

Data from Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

2023Open Access

Supplementary Movie 1 from Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma

2023Open Access

page 1 of 14Next →

Frequent Co-authors

Carl K. Hoh(12), Christiaan Schiepers(11), Johannes Czernin(10), Sung‐Cheng Huang(9), Michael E. Phelps(8), Randall A. Hawkins(7), Nagichettiar Satyamurthy(7), John A. Glaspy(7), Jamshid Maddahi(7), Michael E. Phelps(7), Heinrich R. Schelbert(6), Yong Choi(5), Daniel Silverman(5), Edward J. Hoffman(4), Jorge R. Barrio(4), Simon R. Cherry(4), Timothy F. Cloughesy(4), Jérémie Calais(3), Nielson Tse(3), Sheila Rege(3)